Antidiabetic effect of S-allylcysteine: Effect on plasma and tissue glycoproteins in experimental diabetes

Phytomedicine

Volumn 17, Issue 14, 2010, Pages 1086-1089

  Saravanan, G ^a,b   Ponmurugan, P ^a,c   Senthil Kumar, G P ^b   Rajarajan, T ^d  

^a BHARATHIAR UNIVERSITY   (India)

^b K S RANGASAMY COLLEGE OF ARTS AND SCIENCE AUTONOMOUS   (India)

^c K S RANGASAMY COLLEGE OF TECHNOLOGY   (India)

^d SASTRA UNIVERSITY   (India)

Author keywords

Antidiabetic effect; Garlic; Glycoprotein components; S allylcysteine; Streptozotocin

Indexed keywords

FUCOSE; GLICLAZIDE; GLUCOSE; GLYCOPROTEIN; HEXOSAMINE; HEXOSE; PLASMA PROTEIN; S ALLYLCYSTEINE; SIALIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANIMALS; BLOOD; BLOOD GLUCOSE; CYSTEINE; DIABETES MELLITUS, EXPERIMENTAL; GARLIC; GLICLAZIDE; GLYCOPROTEINS; HYPOGLYCEMIC AGENTS; KIDNEY; LIVER; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR;

ALLIUM SATIVUM; RATTUS;

EID: 78149408617     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.04.008     Document Type: Article

References (34)

1. Aybar M.J., Riera A.N.S., Grau A., Sanchez S.S. Hypoglycemic effect of the water extract of Smallanthus sonchifolius (Yacon) leaves in normal and diabetic rats. J. Ethnopharmacol. 2001, 74:125-132.
2. Berenson G.S., Radhakrishnamurthy Dalferes E.R. Connective tissue macromolecular changes in rats with experimentally induced diabetes and hyperinsulinism. Diabetes 1972, 21:733-743.
3. Block E. The organosulfur chemistry of the genus Allium: implications for the organic chemistry of sulfur. Angew. Chem. Int. Ed. Eng. 1992, 31:1135-1178.
4. Camerini Davalos R.A., Velasco C.A., Reddi A.S. Metabolism of glomerular basement membrane in diabetes. Frontiers in Diabetes 1990, 61-77. Karger, Basel, Switzerland. F. Belfiore, G.M. Molinatti, G.M. Reaven (Eds.).
5. Dische Z., Shettles L.B. A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J. Biol. Chem. 1948, 175:595-603.
6. Gayathri M., Kannabiran K. Antidiabetic and ameliorative potential of Ficus bengalensis bark extract in streptozotocin induced diabetic rats. Indian J. Clin. Biochem. 2008, 23:394-400.
7. Guillot R., Kassab J.P., Ogneva U., Andre J., Durussel J.J., Hadjiisky P., Peyroux J., Sternberg M. Relation between pancreatic islet cellular infiltration and plasma fibrinogen or [alpha]1-acid glycoprotein levels in spontaneously and streptozotocin-diabetic rats: an increase in these protein levels is not necessary for inducing microcirculatory erythrocyte velocity alteration. Pancreas 1994, 9:336-343.
8. Herrera-Mundo M.N., Silva-Adaya D., Maldonado P.D., Galvan-Arzate S., Andres-Martinez L., Perez-De La Cruz V., Pedraza-Chaverri J., Santamaria A. S-allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity early markers of oxidative stress and mitochondrial dysfunction. Neurosci. Res. 2006, 56:39-44.
9. Hii C.S.T., Howell S.L. Effects of epicatechin on rat islets of Langerhans. Diabetes 1984, 33:291-296.
10. Ivorra M.D., Paya M., Villar A. A review of natural products and plants as potential antidiabetic drugs. J. Ethnopharmacol. 1989, 27:243-275.
11. Kaleem M., Asif M., Ahmed Q., Bano B. Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin induced diabetic rats. Singapore Med. J. 2006, 47:670-675.
12. Kimmelsteil P., Wilson C. Inter-capillary lesion in the glomeruli of the kidney. Am. J. Pathol. 1936, 12:83-105.
13. Knecht K.T., Bradford B.U., Mason R.P., Thurman R.G. In vivo formation of a free radicals metabolite of ethanol. Mol. Pharmacol. 1990, 38:26-30.
14. Kumar P.A., Haseeb A., Suryanarayana P. Elevated expression of a A- and a-B crystallins in streptozotocin-induced diabetic rat. Arch. Biochem. Biophys. 2005, 444:77-83.
15. Marshall S., Bacote V., Traxinger R.R. Discovery of metabolic pathway mediating glucose induced desensitization of glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 1991, 266:4706-4712.
16. Mittal N., Keaur J., Mahmood A. Changes in tubular membrane glycosylation in diabetic insulin and thyroxin treated rat kidneys. Indian J. Exp. Biol. 1996, 34:782-785.
17. Niebes P. Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin. Chim. Acta 1972, 42:399-408.
18. Palsamy P., Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin nicotinamide induced experimental diabetic rats. Biomed. Pharmacother. 2008, 62:598-605.
19. Patti M.E., Virkamäki A., Landaker E.J., Kahn C.R., Yki-Järvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early post receptor insulin signaling events in skeletal muscle. Diabetes 1999, 48:1562-1571.
20. Pulido N., Suarez A., Casanova B., Romero R., Rodriguez E., Rovira A. Glyclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle. Metabolism 1997, 46:10-13.
21. Rahman M.A., Zafar G., Shera A.S. Changes in glycosylated proteins in long-term complications of diabetes mellitus. Biomed. Pharmacother. 1990, 44:229-234.
22. Ramkumar K.M., Rajaguru P., Latha M., Ananthan R. Ethanol extract of Gymnema montanum leaves reduces glycoprotein components in experimental diabetes. Nut. Res. 2007, 27:97-103.
23. Rasch R., Torffucit O., Bachmann S., Jensen P.K., Jacobsen N.O. Glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry and urinary excretion. Diabetologia 1955, 32:525-535.
24. Robinson K.A., Weinstein M.L., Lindenmayer G.E., Byse M.G. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 1955, 44:1438-1446.
25. Rolo A.P., Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212:167-178.
26. Saravanan G., Ponmurugan P., Senthil kumar G.P., Rajarajan T. Antidiabetic properties of S-allylcysteine, a garlic component on streptozotocin-induced diabetes in rats. J. Appl. Biomed. 2009, 7:151-159.
27. Saravanan G., Ponmurugan P., Senthil kumar G.P., Rajarajan T. Modulatory effect of S-allylcysteine on glucose metabolism in streptozotocin induced diabetic rats. J. Funct. Foods 2009, 1:336-340.
28. Shanmugasundram E.R.B., Gopinath K.L., Shanmugasundram K.R., Rajendran V.M. Possible regeneration of islets of Langerhans in streptozotocin diabetic rats given Gymnema sylvestre leaf extract. J. Ethnopharmacol. 1990, 30:265-279.
29. Spiro R.G., Spiro M.J. Effect of diabetes on the biosynthesis of the renal glomerular basement membrane. Studies on the glycosyl transferase. Diabetes 1971, 20:641-648.
30. Wagner W.D. A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal. Biochem. 1979, 94:394-396.
31. Warren L. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 1959, 234:1971-1975.
32. Wiese T.J., Dunlap J.A., Yorek M.A. Effect of lfucose and l-glucose concentration on lfucoprotein metabolism in human Hep G2 cells and changes in fucosyltransferase and a l-fucosidase activity in liver of diabetic rats. Biochim. Biophys. Acta 1997, 1:61-72.
33. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
34. Witters L.A. The blooming of the French lilac. J. Clin. Invest. 2001, 108:1105-1107.